
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145847410.1021/acsomega.7b01789ArticleDouble SO2 Insertion into 1,7-Diynes Leading
to Functionalized Naphtho[1,2-c]thiophene
2,2-dioxides Wang Ai-Fang †Hao Wen-Juan *†Zhu Yi-Long †Li Guigen ‡§Zhou Peng ‡Tu Shu-Jiang *†Jiang Bo *†† School
of Chemistry & Materials Science, Jiangsu
Normal University, Xuzhou 221116, P. R. China‡ Institute
of Chemistry & BioMedical Sciences, Nanjing University, Nanjing 210093, P. R. China§ Department
of Chemistry and Biochemistry, Texas Tech
University, Lubbock, Texas 79409-1061, United States* E-mail: wjhao@jsnu.edu.cn (W.-J.H.).* E-mail: laotu@jsnu.edu.cn (S.-J.T.).* E-mail: jiangchem@jsnu.edu.cn (B.J.).05 02 2018 28 02 2018 3 2 1482 1491 16 11 2017 23 01 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.

A novel metal-free
double SO2 insertion/multicomponent
bicyclization cascade of benzene-linked 1,7-diynes has been established
by treatment with aryldiazonium tetrafluoroborates and DABCO–bis(sulfur
dioxide) under redox-neutral conditions, providing a range of dual
sulfone-containing naphtho[1,2-c]thiophene 2,2-dioxides
with generally high stereoselectivity. The reaction pathway is proposed
to proceed through the sequence of arylsulfonyl-radical-induced 6-exo-dig/5-endo-trig
bicyclization, H-abstraction, and diazotization.

document-id-old-9ao7b01789document-id-new-14ao-2017-01789hccc-price
==== Body
Introduction
Sulfone
nucleus is a privileged structural component in a substantial
number of natural products and bioactive substances.1 Among them, benzothiophene dioxides possessing a cyclic
sulfonyl unit have drawn considerable attention owing to their unique
physical and biological activities.2 For
instance, benzothiophene dioxides have been found to behave as an
absorbance and fluorescence switch.3 Specifically,
some benzothiophene dioxides could serve as inhibitors of hepatitis
C virus NS5B polymerase and carbonic anhydrase.4 Consequently, much effort has been made in developing general
methods for the construction of benzothiophene dioxide frameworks.
Most of the synthetic endeavors to assemble these compounds involve
Rh-catalyzed [2 + 2 + 2] cycloadditions of alkynes,5 photochemical cyclization of o-tolualdehydes,6 catalytic Garratt–Braverman cyclization
of dipropargyl sulfones,7 Rh-catalyzed
C–H insertion of α-diazo-β-arylmethanesulfonyl
esters,8 and Pd-catalyzed intramolecular
arylations of enolates.9 Recently, Wu et
al. reported the insertion of sulfur dioxide into 2-alkynylaryldiazonium
tetrafluoroborate10a or (2-alkynylaryl)boronic
acids10b for forming benzothiophene dioxides.
Despite these limited achievements, the development of facile and
efficient protocols toward synthesizing new functionalized benzothiophene
dioxides, starting from readily available substrates under mild conditions,
is still highly desirable.

On the other hand, the insertion
of sulfur dioxide into molecular
skeletons has proven to be a powerful tool for the collection of biologically
interesting sulfone-containing structures like sulfones and sulfonamides
in a convergent manner.11 Over the past
few years, the pioneering work of the group of Willis12 has stimulated extensive studies on the insertion of sulfur
dioxide with nucleophiles (Nu) and electrophiles (E) for sulfone and
sulfonamide syntheses by exploiting bench-stable solid DABCO·(SO2)2 (DABSO) as the source of sulfur dioxide (Scheme 1a).13 Later, Wu and co-workers reported a three-component reaction
of aryldiazonium tetrafluoroborates, DABSO, and aryl propiolates to
afford 3-sulfonated coumarins (Scheme 1b).14 Recently, our group
has established a series of domino radical cyclizations for sulfone-containing
multiple ring formations.15 For example,
we employed benzene-linked allene-ynes as starting materials to subject
them to the reaction of aryldiazonium tetrafluoroborates and DABSO
toward synthesizing sulfone-containing cyclobuta[a]naphthalen-4-ols.15a For this purpose,
we considered preparing diyne-anchored starting material 1(16) by taking advantage of a methodology
in which double SO2 insertion across its C≡C π
system results in functionalized naphtho[1,2-c]thiophene
2,2-dioxide products. As expected, this transformation proceeded smoothly
under redox-neutral conditions to directly form naphtho[1,2-c]thiophene 2,2-dioxides 4 with high diastereoselectivity
(Scheme 1c). Interestingly,
aryldiazonium salts play dual roles as an aryl radical donor as well
as an azo source, which were trapped by DABSO and 1,7-diynes, thereby
simultaneously installing both sulfonyl group and azo functionality
into the molecular skeleton via radical addition. The present approach
represents the first radical-triggered multicomponent dehydrobicyclization
cascade of 1,7-diynes for the direct synthesis of these new naphtho[1,2-c]thiophene 2,2-dioxides via double SO2 insertion
in a one-pot manner without any additional oxidant. Herein, we elaborated
this unprecedented radical dehydrobicyclization transformation.

Scheme 1 Profiles for S-Centered Radical Cyclization
Results and Discussion
Our initial investigation commenced
with the treatment of benzene-tethered
1,7-diyne 1a with p-methoxyphenyl (PMP)
diazonium tetrafluoroborate (2a) and DABSO (3) in 1:2:2.5 mole ratio at 60 °C under Ar conditions using 1,2-dichloroethane
(DCE) as the reaction medium. The reaction proceeded to generate naphtho[1,2-c]thiophene 2,2-dioxide 4a bearing an unexpected
azo group, albeit with a low 15% yield (Table 1, entry 1). Interestingly, the analysis of 1H NMR and X-ray diffraction of product 4a revealed
that high diastereoselectivity in 20:1 dr was observed (Figure 1). This exciting result prompted
us to undertake further investigations. Because of this molecular
framework incorporating two SO2 and two PMP units, we then
adjusted the substrate ratio to 1:2:3, and the reaction provided a
slightly higher yield of 4a (27%, entry 2). The following
careful screening of the substrate ratio (entries 3–6) showed
that the substrate ratio 1:4:3 remarkably facilitated this reaction
process and afforded a higher yield (43%). Subsequently, the effect
of solvent on this transformation was investigated using various solvents
such as dichloromethane (DCM), acetonitrile (CH3CN), 1,4-dioxane, N,N-dimethylformamide (DMF), toluene, and
tetrahydrofuran (THF). The use of DCM remarkably decreased the yield
to 29% (entry 7), whereas other attempted solvents completely suppressed
the reaction process (entries 8–12). Elevating the reaction
temperature to 70 °C was not beneficial to the transformation,
accessing 4a in a reduced yield (37%, entry 13). In contrast,
a decrease of the reaction temperature could promote the conversion
of 1,7-diyne 1a into product 4a as a higher
yield (48%) was obtained with the reaction temperature being 50 °C
(entry 14). Further lowering the reaction temperature to 40 °C
showed no positive effect on the yield of 4a (entry 15).
To our delight, use of 0.5 equiv of Et3N as a base promoter
efficiently facilitated this double SO2 insertion, delivering
product 4a in a higher yield (56%, entry 16).

Figure 1 Oak Ridge thermal
ellipsoid plot drawing of 4a.

Table 1 Optimization of Reaction Conditionsa
entry	substrate
ratio	solvent	t (°C)	yield (%)b	
1	1:2:2.5 (1a:2a:3)	DCE	60	15	
2	1:2:3 (1a:2a:3)	DCE	60	27	
3	1:2:4 (1a:2a:3)	DCE	60	NDc	
4	1:3:3 (1a:2a:3)	DCE	60	19	
5	1:3:4 (1a:2a:3)	DCE	60	trace	
6	1:4:3 (1a:2a:3)	DCE	60	43	
7	1:4:3 (1a:2a:3)	DCM	60	29	
8	1:4:3 (1a:2a:3)	CH3CN	60	trace	
9	1:4:3 (1a:2a:3)	1,4-dioxane	60	ND	
10	1:4:3 (1a:2a:3)	DMF	60	trace	
11	1:4:3 (1a:2a:3)	toluene	60	NRd	
12	1:4:3 (1a:2a:3)	THF	60	NR	
13	1:4:3 (1a:2a:3)	DCE	70	37	
14	1:4:3 (1a:2a:3)	DCE	50	48	
15	1:4:3 (1a:2a:3)	DCE	40	41	
16	1:4:3 (1a:2a:3)	DCE	50	56e	
a Reaction conditions: 1a, 0.4 mmol; 2a, x equiv; DABSO, y equiv; solvent, 2.5 mL; under Ar conditions, 1.5 h.

b Isolated yield based on 1a.

c ND, not detected.

d NR, no reaction.

e Use of Et3N, 0.5 equiv.

With these acceptable reaction
conditions in hand, we then systematically
studied the generality of this metal-free multicomponent dehydrobicyclization
cascade toward synthesizing naphtho[1,2-c]thiophene
2,2-dioxides 4 by examining 1,7-diyne and aryldiazonium
tetrafluoroborate components (Scheme 2). First, 1,7-diynes with different functional groups
were evaluated in combination with p-methoxyphenyl
(PMP) diazonium tetrafluoroborate (2a) and DABSO (3). Substituents bearing both electronically rich and poor
properties at different positions of arylalkynyl (R1) moiety
could be successfully engaged in this transformation, generating corresponding
products 4a–h with 39–67%
yields and high diastereoselectivity (6:1 to 20:1 dr). Functional
groups like methyl (1b and 1c), ethyl (1d), t-butyl (1e), methoxy (1f), and chloride (1g) were tolerated with these
optimal conditions, some of which needed to fine-tune the reaction
temperatures. For instance, 1,7-diyne 1f carrying a methoxy
group (R1) was subjected to the reaction of 2a with 3 at 30 °C, furnishing the desired product 4f in 62% yield, whereas the presence of slight electron-withdrawing
chloro group seemed to lower the efficiency of this dehydrobicyclization
reaction, as the corresponding product 4g was isolated
in a decreased (39%) yield, although with a reaction temperature of
60 °C. Alternatively, 1,7-diyne 1h with a n-butyl group was proven to be a suitable reaction partner,
enabling the radical-induced dehydrobicyclization process toward synthesizing
naphtho[1,2-c]thiophene 2,2-dioxide 4h with 56% yield and 6:1 dr. 1,7-Diynes 1 having either
electron-donating (Me, 1i–j and MeO, 1k–m) or -withdrawing (Cl, 1n–r) substituents (R2) at the C4- or
C5-position of the internal arene ring readily participated in the
current dehydrobicyclization cascades, enabling metal-free sulfonylation
and diazotization to access functionalized naphtho[1,2-c]thiophene 2,2-dioxides 4i–r in
45–72% yields and 15:1 to 20:1 dr. The reaction can tolerate
various aryldiazonium tetrafluoroborates 2b–e with both electron-rich groups (ethoxy 2b,
dimethoxy 2c, and methyl 2d) at the para-position
of arene ring and neutral (H, 2e) groups, leading to
the formation of naphtho[1,2-c]thiophene 2,2-dioxides 4s–w with yields ranging from 43 to 62%
and 10:1 to 15:1 dr. Unluckily, aryldiazonium tetrafluoroborate 2f having a chloro group was an ineffective partner, as the
reaction failed to work under standard conditions (Scheme 2, 4x). Moreover,
1,7-diyne 1k possessing a methoxy group located at the
C5-position of the internal arene ring was utilized to react with 2a and 3, and the corresponding product 4y was offered in 48% yield and 10:1 dr. Similarly, ester-protected
1,7-diyne still showed high reactivity, enabling its conversion into
product 4z with 55% yield and 15:1 dr. In the case of 4a, its stereostructure was unequivocally confirmed by carrying
out single-crystal X-ray diffraction (Figure 1).

Scheme 2 Substrate Scope for Forming Products 4,,
Reaction conditions: 1, 0.4 mmol; 2, 1.6 mmol; DABSO, 1.2 mmol; Et3N, 0.2 mmol; DCE, 2.5 mL; 50 oC, under Ar conditions,
1.5 h; isolated yields in brackets based on 1,7-diynes 1; dr value based on their 1H NMR analysis.

The reaction was conducted at 30 oC.

The reaction
was conducted at 60 oC.

To gain
more mechanistic insight into this transformation, several
control experiments were performed. The presence of 3.0 equiv of 2,2,6,6-tetramethyl-1-piperidinyloxy
(TEMPO) or butylhydroxytoluene completely suppressed the generation
of normal product 4a (Scheme 3a). Among them, a TEMPO–PMP adduct
was detected by liquid chromatography–mass spectrometry (LC–MS)
analysis, indicating that the reaction process might include in situ
generation of aryl radicals. Treatment of 1a with 2a and DABSO under standard conditions resulted in 4a in 56% yield, together with anisole 5, 4-methoxybenzenesulfinic
acid 6, 4-methoxybenzenesulfonyl fluoride 7, and sulfuryl difluoride (Scheme 3b), and byproducts 5, 6,
and 7 were detected by LC–MS analysis. These results
revealed that the in situ generation of aryl and arylsulfonyl radicals
could abstract hydrogen atoms from 1,7-diynes to convert into the
corresponding benzenes and arylsulfinic acids, and arylsulfonyl radicals
act as a reduction reagent. As radical acceptors, aryldiazonium salts
have previously been proven to be converted into radical cations of
azo compounds via radical cross-coupling with radical species, which
gain an electron to facilitate access to azo compounds through a single
electron transfer (SET) process.17 For
this reason, we believed that during this reaction process SO2 serves as another reduction reagent and is oxidized and trapped
by the fluoride anion to access sulfuryl difluoride (Scheme 3b), but it is difficult to
be detected as it is a gas. To support the above analysis and certify
the redox pathway, potassium bromide (KBr) was subjected to the reaction
of 1a with 2a and DABSO under standard conditions
(Scheme 3c). As expected,
both sulfuryl dibromide 8 and sulfuryl bromide 9 were observed by LC–MS analysis. Next, in the presence
of naphthalen-1-ol, the reaction gave naphthalen-1-yl sulfurofluoridate 10 (observed by LC–MS, Scheme 3d). These results further supported the above
analysis.

Scheme 3 Control Experiments
Combining the aforementioned observations and previous
reports,13,14 a reasonable mechanism is proposed in Scheme 4. The combination
of aryldiazonium cations
and DABSO is anticipated to give radical cation intermediates A, SO2, and aryl radicals by the homolytic cleavage
of the N–S bond and a SET process.14,18 Then, aryl radicals are intercepted by SO2 to generate
arylsulfonyl radicals. Subsequently, radical addition of aryl sulfonyl
radicals into 1,7-diynes 1 gives intermediates B,19 followed by 6-exo-dig cyclization
to vinyl radicals C,20 which
are trapped by SO2 to sulfonyl radicals D.
Sulfonyl radicals D triggered 5-endo-trig cyclization,
giving intermediates E, which undergo SET and base-promoted
deprotonation to yield intermediates G. A subsequent
hydrogen atom transfer (H-abstraction) between G and
aryl/arylsulfonyl radicals yields benzenes/arylsulfinic acids and
radical intermediates H, trapped by aryldiazonium cations
via radical cross-coupling to afford radical cations I. Next, in the presence of tetrafluoroborate anions, intermediates I react with SO2 and/or aryl sulfonyl radicals
via a redox process to give naphtho[1,2-c]thiophene
2,2-dioxides J, sulfuryl difluorides, and aryl sulfonyl
fluoride.15a Intermediates J are converted into final products 4 through 1,3-H transfer.

Scheme 4 Plausible Mechanism Pathway
In conclusion, we have discovered an unprecedented double
SO2 insertion into benzene-linked 1,7-diynes under mild
redox-neutral
conditions, by which disulfone-containing naphtho[1,2-c]thiophene 2,2-dioxides with a wide diversity in substituents were
diastereoselectively synthesized through arylsulfonyl-radical-induced
6-exo-dig/5-endo-trig bicyclization. Notably, aryldiazonium salts
play dual roles as the reaction initiator as well as the reaction
terminator, installing the sulfonyl group and azo functionality into
the molecular skeleton via radical addition. The reaction enabled
direct construction of six new σ bond including C–S,
C–C, and C–N bonds by combining aryldiazonium salts,
DABSO, and C(sp3)-linked 1,7-diynes under catalyst-free
conditions, providing an easy and metal-free protocol toward synthesizing
a range of richly decorated naphtho[1,2-c]thiophene
2,2-dioxides. Further investigation on mechanistic insights and its
applications will be conducted in due course.

Experimental Section
General
Procedure for the Synthesis of Compounds 1
Under Ar conditions, a mixture of 2-bromobenzaldehyde (10.0 mmol),
CuI (2 mol %), PdCl2(PPh3)2 (2 mol
%), and Et3N (60 mL) as a solvent was stirred at 50 °C.
Then, ethynylbenzene (1.05 equiv) was dropwise added into the reaction
system. The resulting reaction mixture was stirred until thin-layer
chromatography (TLC) indicated complete consumption of the starting
material. After filtration through a pad of Celite rinsing with Et2O, the residue was purified by chromatography on silica gel
with petroleum ether/ethyl acetate as the eluent to afford compound I (90–100% yield).

Under an Ar atmosphere, a
mixture of compound I (5.0 mmol, 1.0 equiv), 3-bromoprop-1-yne
(1.5 equiv), and zinc powder (4 equiv) in 60 mL of THF/DMF (1/1) was
stirred at room temperature, and the reaction system was detected
by TLC. After completion of the reaction, the residue was quenched
with saturated NH4Cl solution, extracted with ethyl acetate,
and dried on MgSO4. After removal of the solvent, the crude
product was purified by column chromatography (EtOAc/hexanes, 1:10)
to give compound II as a white solid (80–90% yield).

To a solution of compound II (4.0 mmol, 1.0 equiv)
in anhydrous THF (20 mL), NaH (2.0 equiv) was added dropwise at 0
°C. After stirring for 0.5 h, CH3I (1.2 equiv) was
added and then the reaction mixture was stirred at room temperature.
After the mixture was stirred overnight, the reaction mixture was
quenched with saturated NH4Cl solution, extracted with
ethyl acetate, and dried on MgSO4. After removal of the
solvent, the crude product was purified by column chromatography (EtOAc/hexanes,
1:100) to give compound 1 (oil, 80–95% yield).

Synthesis of Compound 1s
To a solution
of compound II (4.0 mmol, 1.0 equiv), pyridine (3.0 equiv),
and 4-dimethylaminopyridine (20 mol %) in anhydrous dichloromethane
(15 mL) at 0 °C was slowly added Ac2O (2 equiv). The
reaction mixture was stirred for 6 h, and then 20 mL of saturated
aqueous sodium bicarbonate was added. The aqueous layer was extracted
with dichloromethane, and the combined organic layer was dried over
MgSO4 and concentrated in vacuo. Purification by flash
chromatography delivered 1z (oil, 75–80% yield).

1-(1-Methoxybut-3-yn-1-yl)-2-(phenylethynyl)benzene
(1a)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.68–7.63 (m, 3H), 7.61 (d, J = 1.2 Hz, 1H), 7.46–7.41 (m, 4H), 7.36–7.32
(m, 1H),
5.12–5.07 (m, 1H), 3.44 (s, 3H), 2.92–2.86 (m, 1H),
2.80–2.73 (m, 1H), 2.19–2.06 (m, 1H). 13C
NMR (100 MHz, CDCl3; δ, ppm) 142.4, 132.2, 131.6,
128.8, 128.6(3), 128.6(6), 127.7, 125.7, 123.1, 122.0, 95.0, 86.9,
81.1, 79.5, 70.1, 57.5, 27.0.

1-(1-Methoxybut-3-yn-1-yl)-2-(p-tolylethynyl)benzene
(1b)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.63–7.59 (m, 2H), 7.55 (d, J = 8.4 Hz, 2H), 7.46–7.41 (m, 1H), 7.36–7.31
(m, 1H), 7.23 (d, J = 8.0 Hz, 2H), 5.16–5.01
(m, 1H), 3.44 (s, 3H), 2.92–2.83 (m, 1H), 2.80–2.71
(m, 1H), 2.43 (s, 3H), 2.16–2.06 (m, 1H). 13C NMR
(100 MHz, CDCl3; δ, ppm) 142.3, 138.7, 132.1, 131.5,
129.3, 128.6, 127.6, 125.7, 122.2, 120.1, 95.2, 86.2, 81.1, 79.5,
69.9, 57.5, 27.0, 21.6.

1-(1-Methoxybut-3-yn-1-yl)-2-(m-tolylethynyl)benzene
(1c)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.57 (d, J = 8.0
Hz, 2H), 7.45–7.40 (m, 3H), 7.35–7.28 (m, 2H), 7.21
(d, J = 7.6 Hz, 1H), 5.05–5.01 (m, 1H), 3.41
(s, 3H), 2.88–2.81 (m, 1H), 2.74–2.67 (m, 1H), 2.41
(s, 3H), 2.10–2.02 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 142.2, 138.2, 132.1, 129.5, 128.6(4), 128.6(2),
128.4, 127.6, 125.6, 122.9, 122.0, 95.1, 86.4, 81.0, 79.4, 69.8, 57.5,
26.9, 21.3.

1-((4-Ethylphenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene
(1d)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.53 (d, J = 8.0
Hz, 2H), 7.50–7.47 (m, 2H), 7.40–7.36 (m, 1H), 7.31–7.26
(m, 1H), 7.21 (d, J = 8.0 Hz, 2H), 5.00–4.96
(m, 1H), 3.37 (s, 3H), 2.83–2.76 (m, 1H), 2.71–2.67
(m, 2H), 2.67–2.61 (m, 1H), 2.04–2.00 (m, 1H), 1.26
(t, J = 7.6 Hz, 3H). 13C NMR (100 MHz,
CDCl3; δ, ppm) 145.0, 142.1, 132.0, 131.5, 128.5,
128.0, 127.5, 125.6, 122.1, 120.2, 95.1, 86.0, 81.0, 79.3, 69.7, 57.5,
28.9, 26.9, 15.4.

1-((4-(tert-Butyl)phenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene
(1e)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.61–7.49 (m, 4H), 7.47–7.36
(m, 3H), 7.35–7.29 (m, 1H), 5.09–4.94 (m, 1H), 3.39
(s, 3H), 2.86–2.77 (m, 1H), 2.73–2.64 (m, 1H), 2.08–2.01
(m, 1H), 1.37 (s, 9H). 13C NMR (100 MHz, CDCl3; δ, ppm) 151.9, 142.2, 132.0, 131.3, 128.5, 127.5, 125.6,
125.5, 122.1, 120.0, 95.0, 86.0, 81.0, 79.3, 69.7, 57.5, 34.8, 31.2,
26.9.

1-(1-Methoxybut-3-yn-1-yl)-2-((4-methoxyphenyl)ethynyl)benzene
(1f)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.55–7.51 (m, 4H), 7.41–7.37
(m, 1H), 7.33–7.28 (m, 1H), 6.93 (d, J = 8.8
Hz, 2H), 5.02–4.98 (m, 1H), 3.87 (s, 3H), 3.39 (s, 3H), 2.85–2.79
(m, 1H), 2.71–2.64 (m, 1H), 2.06–2.03 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 159.8, 142.0,
133.0, 131.9, 128.3, 127.5, 125.5, 122.2, 115.1, 114.1, 94.9, 85.4,
81.1, 79.4, 69.7, 57.5, 55.4, 26.9.

1-((4-Chlorophenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene
(1g)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.55 (d, J = 7.6
Hz, 2H), 7.53–7.50 (m, 2H), 7.45–7.41 (m, 1H), 7.39–7.36
(m, 2H), 7.34–7.30 (m, 1H), 4.98–4.95 (m, 1H), 3.39
(s, 3H), 2.83–2.77 (m, 1H), 2.71–2.65 (m, 1H), 2.05–2.04
(m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm)
141.3, 133.5, 131.7, 131.1, 127.9, 127.8, 126.6, 124.6, 120.5, 120.5,
92.6, 86.6, 79.9, 78.4, 68.8, 56.4, 25.9.

1-(Hex-1-yn-1-yl)-2-(1-methoxybut-3-yn-1-yl)benzene
(1h)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.48 (d, J = 8.0
Hz, 1H), 7.41 (d, J = 7.6 Hz, 1H), 7.35–7.30
(m, 1H), 7.25–7.20
(m, 1H), 4.92–4.87 (m, 1H), 3.34 (s, 3H), 2.75–2.69
(m, 1H), 2.63–2.56 (m, 1H), 2.50–2.46 (m, 2H), 2.03–2.00
(m, 1H), 1.68–1.61 (m, 2H), 1.58–1.50 (m, 2H), 0.99
(t, J = 7.4 Hz, 3H). 13C NMR (100 MHz,
CDCl3; δ, ppm) 142.0, 132.1, 127.8, 127.4, 125.4,
122.7, 96.0, 81.1, 79.2, 78.0, 69.5, 57.3, 30.8, 26.8, 22.1, 19.2,
13.6.

1-(1-Methoxybut-3-yn-1-yl)-4-methyl-2-(p-tolylethynyl)benzene
(1i)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.51 (d, J = 8.0
Hz, 2H), 7.47 (d, J = 8.0 Hz, 1H), 7.41 (s, 1H),
7.25–7.21 (m, 3H), 5.04–5.00 (m, 1H), 3.41 (s, 3H),
2.87–2.80 (m, 1H), 2.75–2.68 (m, 1H), 2.43 (s, 3H),
2.40 (s, 3H), 2.08–2.06 (m, 1H). 13C NMR (100 MHz,
CDCl3; δ, ppm) 139.2, 138.6, 137.3, 132.5, 131.5,
129.5, 129.2, 125.6, 122.0, 120.1, 94.7, 86.3, 81.2, 79.2, 69.8, 57.4,
27.0, 21.6, 21.0.

2-((4-Chlorophenyl)ethynyl)-1-(1-methoxybut-3-yn-1-yl)-4-methylbenzene
(1j)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.52–7.48 (m, 2H), 7.43 (d, J = 8.0 Hz, 1H), 7.39–7.35 (m, 3H), 7.24 (d, J = 7.6 Hz, 1H), 4.95–4.91 (m, 1H), 3.37 (s, 3H),
2.80–2.73 (m, 1H), 2.70–2.63 (m, 1H), 2.38 (s, 3H),
2.06–2.01 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 139.3, 137.4, 134.5, 132.7, 132.6, 129.9, 128.8,
125.6, 121.6, 121.5, 93.2, 87.9, 81.0, 79.2, 69.7, 57.4, 27.0, 20.9.

4-Methoxy-2-(1-methoxybut-3-yn-1-yl)-1-(phenylethynyl)benzene
(1k)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.56 (m, 2H), 7.49 (d, J = 8.4 Hz, 1H), 7.42–7.36 (m, 3H), 7.11 (d, J = 2.8 Hz, 1H), 6.88–6.84 (m, 1H), 4.99–4.95 (m, 1H),
3.88 (s, 3H), 3.41 (s, 3H), 2.85–2.79 (m, 1H), 2.70–2.63
(m, 1H), 2.10–2.04 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 160.1, 144.2, 133.5, 131.4, 128.4, 128.2,
123.4, 113.9, 113.7, 110.8, 93.5, 86.7, 80.9, 79.3, 69.8, 57.6, 55.4,
26.9.

4-Methoxy-2-(1-methoxybut-3-yn-1-yl)-1-(p-tolylethynyl)benzene
(1l)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.50–7.42 (m, 3H), 7.19 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 2.8 Hz, 1H),
6.87–6.83 (m, 1H), 4.99–4.95 (m, 1H), 3.87 (s, 3H),
3.41 (s, 3H), 2.85–2.79 (m, 1H), 2.69–2.62 (m, 1H),
2.40 (s, 3H), 2.08–2.03 (m, 1H). 13C NMR (100 MHz,
CDCl3; δ, ppm) 159.9, 144.1, 138.3, 133.4, 131.2,
129.2, 120.3, 114.2, 113.7, 110.8, 93.7, 86.0, 81.0, 79.3, 69.8, 57.6,
55.4, 26.8, 21.5.

1-((4-Chlorophenyl)ethynyl)-4-methoxy-2-(1-methoxybut-3-yn-1-yl)benzene (1m)
White oil; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.50–7.46 (m, 3H), 7.37–7.33
(m, 2H), 7.10 (d, J = 2.8 Hz, 1H), 6.88–6.84
(m, 1H), 4.95–4.91 (m, 1H), 3.88 (s, 3H), 3.40 (s, 3H), 2.83–2.76
(m, 1H), 2.69–2.61 (m, 1H), 2.07–2.04 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 160.3, 144.3,
134.1, 133.6, 132.5, 128.7, 121.9, 113.7, 113.6, 110.9, 92.4, 87.7,
80.9, 79.4, 69.8, 57.6, 55.4, 26.9.

4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-(phenylethynyl)benzene
(1n)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.59–7.54 (m, 3H), 7.49 (d, J = 8.4 Hz, 1H), 7.42–7.38 (m, 3H), 7.31–7.29
(m, 1H), 4.96–4.92 (m, 1H), 3.41 (s, 3H), 2.84–2.77
(m, 1H), 2.71–2.64 (m, 1H), 2.08–2.04 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 144.2, 134.9,
133.3, 131.5, 128.8, 128.5, 127.9, 126.1, 122.7, 120.3, 95.7, 85.6,
80.4, 79.0, 70.1, 57.7, 26.7.

4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-(p-tolylethynyl)benzene
(1o)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.54 (d, J = 2.0
Hz, 1H), 7.49–7.45 (m, 3H), 7.30–7.27 (m, 1H), 7.21
(d, J = 8.0 Hz, 2H), 4.97–4.92 (m, 1H), 3.40
(s, 3H), 2.84–2.77 (m, 1H), 2.70–2.63 (m, 1H), 2.41
(s, 3H), 2.07–2.04 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 144.1, 139.0, 134.6, 133.2, 131.4, 129.3,
127.9, 126.0, 120.5, 119.6, 96.0, 85.0, 80.5, 79.0, 70.1, 57.7, 26.7,
21.6.

4-Chloro-1-((4-ethylphenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene
(1p)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.54 (d, J = 2.0
Hz, 1H), 7.51–7.46 (m, 3H), 7.30–7.27 (m, 1H), 7.24
(d, J = 8.0 Hz, 2H), 4.96–4.92 (m, 1H), 3.40
(s, 3H), 2.84–2.77 (m, 1H), 2.73–2.69 (m, 2H), 2.68–2.63
(m, 1H), 2.07–2.05 (m, 1H), 1.28 (t, J = 7.6
Hz, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm)
145.3, 144.1, 134.6, 133.2, 131.5, 128.1, 127.9, 126.0, 120.5, 119.8,
96.0, 85.0, 80.4, 79.0, 70.1, 57.7, 28.9, 26.7, 15.4.

1-((4-(tert-Butyl)phenyl)ethynyl)-4-chloro-2-(1-methoxybut-3-yn-1-yl)benzene
(1q)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.55–7.49 (m, 3H), 7.47 (d, J = 8.4 Hz, 1H), 7.42 (d, J = 8.4 Hz, 2H),
7.30–7.27 (m, 1H), 4.96–4.92 (m, 1H), 3.40 (s, 3H),
2.83–2.76 (m, 1H), 2.70–2.62 (m, 1H), 2.06–2.05
(m, 1H), 1.36 (s, 9H). 13C NMR (100 MHz, CDCl3; δ, ppm) 152.2, 144.1, 134.6, 133.2, 131.3, 127.9, 126.0,
125.5, 120.5, 119.7, 95.9, 85.0, 80.4, 79.0, 70.1, 57.7, 34.9, 31.2,
26.6.

4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-((4-methoxyphenyl)ethynyl)benzene
(1r)
White oil; 1H NMR (400 MHz,
CDCl3; δ, ppm) 7.56–7.49 (m, 3H), 7.46 (d, J = 8.4 Hz, 1H), 7.29–7.26 (m, 1H), 6.96–6.90
(m, 2H), 4.95–4.91 (m, 1H), 3.86 (s, 3H), 3.40 (s, 3H), 2.84–2.77
(m, 1H), 2.69–2.63 (m, 1H), 2.07–2.05 (m, 1H). 13C NMR (100 MHz, CDCl3; δ, ppm) 160.0, 143.9,
134.4, 133.1, 133.0, 127.9, 126.0, 120.7, 114.8, 114.2, 95.9, 84.4,
80.5, 79.1, 70.1, 57.7, 55.4, 26.7.

1-(2-(Phenylethynyl)phenyl)but-3-yn-1-yl
acetate (1s)
White oil; 1H NMR (400
MHz, CDCl3; δ, ppm) 7.64–7.57 (m, 3H), 7.54
(d, J = 7.6 Hz, 1H), 7.42–7.38 (m, 4H), 7.36–7.32
(m, 1H),
6.51–6.47 (m, 1H), 3.03–2.97 (m, 1H), 2.92–2.85
(m, 1H), 2.20 (s, 3H), 2.05–2.03 (m, 1H). 13C NMR
(100 MHz, CDCl3; δ, ppm) 169.9, 140.6, 132.3, 131.6,
128.6, 128.5, 128.4, 128.0, 125.8, 123.0, 121.4, 95.3, 86.4, 79.5,
71.7, 70.7, 25.3, 21.1.

General Procedure for the
Synthesis of Products 4
Example for the synthesis
of 4a: To a 25 mL
Schlenk tube under Ar conditions, 1-(1-methoxybut-3-yn-1-yl)-2-(phenylethynyl)benzene
(1a, 0.4 mmol, 104 mg, 1.0 equiv), 1,4-diazabicyclo[2.2.2]octane
bis(sulfur dioxide) adduct (3, 1.2 mmol, 288 mg, 3.0
equiv), 4-methoxybenzenediazonium tetrafluoroborate (2a, 1.6 mmol, 355 mg, 4.0 equiv), triethylamine (0.2 mmol, 20 mg, 0.5
equiv), and 1,2-dichloroethane (2.5 mL) were successively added. Then,
the tube was stirred at 50 °C for 1.5 h until complete consumption
of 1a, as monitored by TLC analysis. After the reaction
was completed, the reaction mixture was concentrated in vacuum and
the resulting residue was purified by column chromatography on silica
gel (eluent, petroleum ether/ethyl acetate = 3:1) to afford the desired
product 4a as a red solid.

(E)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4a, Major)
141 mg, 56%; red solid, mp 153–154 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.81 (d, J = 8.8 Hz, 2H), 7.71–7.46 (m, 9H), 7.19 (s, 2H), 7.06 (d, J = 8.4 Hz, 2H), 6.60 (d, J = 8.8 Hz, 2H),
6.36 (s, 1H), 5.92 (s, 1H), 3.97 (s, 3H), 3.60 (s, 3H), 3.12 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.5,
148.1, 147.0, 138.7, 136.5, 135.8, 132.3, 131.1, 130.7(4), 130.7(8),
130.5, 129.8, 129.4, 128.3, 128.1, 127.7, 127.2, 126.3, 126.1, 114.3,
114.0, 69.2, 55.8, 55.5, 54.2. IR (film, ν, cm–1) 2933, 2840, 1595, 1577, 1498, 1337, 1146, 838. HR-MS (ESI) m/z calcd for C33H28N2NaO7S2 [M + Na]+ 651.1236,
found 651.1237.

(E)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4b, Major)
149 mg, 58%; red solid,
mp 188–189 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.81 (d, J = 8.8 Hz, 2H), 7.67–7.60
(m, 3H), 7.53–7.46 (m, 3H), 7.32 (d, J = 8.0
Hz, 2H), 7.25 (d, J = 8.0 Hz, 1H), 7.22–7.16
(m, 1H), 7.05 (d, J = 9.2 Hz, 2H), 6.59 (d, J = 8.8 Hz, 2H), 6.35 (s, 1H), 5.92 (s, 1H), 3.96 (s, 3H),
3.60 (s, 3H), 3.11 (s, 3H), 2.46 (s, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 164.3, 163.4, 147.9, 147.0, 141.2,
139.0, 136.1, 135.7, 132.2, 131.0, 130.7, 130.4, 130.2, 130.0, 128.3,
128.2, 127.7, 127.3, 126.0, 123.2, 114.3, 114.0, 69.2, 55.8, 55.5,
54.2, 21.6. IR (film, ν, cm–1) 2934, 2855,
1594, 1497, 1336, 1145, 831. HR-MS (ESI) m/z calcd for C34H30N2NaO7S2 [M + Na]+ 665.1392, found 665.1387.

(E)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(m-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4c, Major)
164 mg, 64%; red solid,
mp 182–183 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.80 (d, J = 8.8 Hz, 2H), 7.67–7.61
(m, 3H), 7.52–7.48 (m, 1H), 7.44–7.35 (m, 4H), 7.24–7.16
(m, 2H), 7.05 (d, J = 8.8 Hz, 2H), 6.60 (d, J = 9.2 Hz, 2H), 6.36 (s, 1H), 5.91 (s, 1H), 3.96 (s, 3H),
3.60 (s, 3H), 3.11 (s, 3H), 2.43 (s, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 164.3, 163.5, 148.0, 147.0, 139.3,
139.0, 136.3, 135.7, 132.2, 131.6, 131.1, 130.8, 130.6, 129.9, 129.3,
128.3, 128.2, 127.8, 127.6, 127.2, 126.2, 126.1, 114.3, 114.0, 69.2,
55.8, 55.5, 54.2, 21.4. IR (film, ν, cm–1)
2929, 2844, 1593, 1577, 1498, 1334, 1255, 1149, 838. HR-MS (ESI) m/z calcd for C34H30N2NaO7S2 [M + Na]+ 665.1392,
found 665.1390.

(E)-1-(4-Ethylphenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4d, Major)
160 mg, 61%; red solid, mp 171–172 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.81 (d, J = 8.8 Hz, 2H), 7.67–7.61 (m, 3H), 7.53–7.47 (m, 3H),
7.34 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 7.6 Hz, 1H), 7.21–7.16 (m, 1H), 7.05 (d, J = 9.2 Hz, 2H), 6.59 (d, J = 8.8 Hz, 2H), 6.35 (s,
1H), 5.92 (s, 1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.12 (s, 3H), 2.79–2.73
(m, 2H), 1.31 (t, J = 7.6 Hz, 3H). 13C
NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.5, 147.9,
147.3, 147.0, 139.0, 136.1, 135.7, 132.2, 131.0, 130.7, 130.4, 130.0,
129.0, 128.3, 128.2, 127.7, 127.2, 127.1, 126.1, 123.4, 114.3, 114.0,
69.2, 55.8, 55.5, 54.2, 28.9, 15.2. IR (film, ν, cm–1) 2965, 2839, 1594, 1577, 1496, 1332, 1260, 1145, 829. HR-MS (ESI) m/z calcd for C35H32N2NaO7S2 [M + Na]+ 679.1549,
found 679.1552.

(E)-1-(4-(tert-Butyl)phenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4e, Major)
183 mg, 67%; red solid, mp 172–173 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.81 (d, J = 8.8 Hz, 2H), 7.67–7.61 (m, 3H), 7.55–7.47 (m, 5H),
7.27–7.18 (m, 2H), 7.05 (d, J = 9.2 Hz, 2H),
6.59 (d, J = 8.8 Hz, 2H), 6.36 (s, 1H), 5.93 (s,
1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.11 (s, 3H), 1.39 (s, 9H). 13C NMR (100 MHz, DMSO-d6; δ,
ppm) 164.2, 163.7, 154.2, 148.3, 146.9, 138.6, 136.6, 136.0, 132.2,
131.7, 131.5, 130.2, 130.1, 128.9, 127.9, 127.2, 127.1, 127.0, 123.6,
114.9, 114.7, 76.7, 69.1, 56.4, 55.9, 55.1, 35.3, 31.4. IR (film,
ν, cm–1) 2964, 2846, 1617, 1595, 1407, 1326,
1145, 838. HR-MS (ESI) m/z calcd
for C37H36N2NaO7S2 [M + Na]+ 707.1862, found 707.1863.

(E)-5-Methoxy-1-(4-methoxyphenyl)-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4f)
163 mg,
62%; red solid, mp 157–158 °C; 1H NMR (400
MHz, CDCl3; δ, ppm) 7.81 (d, J =
8.8 Hz, 2H), 7.65–7.61 (m, 3H), 7.56 (d, J = 8.8 Hz, 2H), 7.52–7.47 (m, 1H), 7.23–7.18 (m, 1H),
7.07–7.02 (m, 5H), 6.59 (d, J = 8.8 Hz, 2H),
6.35 (s, 1H), 5.91 (s, 1H), 3.96 (s, 3H), 3.91 (s, 3H), 3.60 (s, 3H),
3.12 (s, 3H). 13C NMR (100 MHz, CDCl3; δ,
ppm) 164.3, 163.4, 161.7, 147.8, 147.1, 138.7, 135.7, 132.2, 132.0,
130.9, 130.7, 130.0, 128.4, 128.2, 127.6, 127.3, 126.0, 118.1, 115.0,
114.3, 114.0, 69.3, 55.8, 55.5, 55.4, 54.2. IR (film, ν, cm–1) 2933, 2842, 1600, 1578, 1499, 1322, 1257, 1146,
836. HR-MS (ESI) m/z calcd for C34H30N2NaO8S2 [M
+ Na]+ 681.1341, found 681.1342.

(E)-1-(4-Chlorophenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4g, Major)
103 mg, 39%; red solid, mp 181–182 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.83–7.78 (m,
2H), 7.67–7.61 (m, 3H), 7.59–7.50 (m, 5H), 7.25–7.18
(m, 2H), 7.06 (d, J = 9.2 Hz, 2H), 6.60 (d, J = 8.8 Hz, 2H), 6.35 (s, 1H), 5.89 (s, 1H), 3.97 (s, 3H),
3.60 (s, 3H), 3.14 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.4, 163.6, 148.5, 147.0, 137.3, 137.2,
137.0, 135.9, 132.2, 131.9, 131.3, 130.8, 129.8, 129.5, 128.4, 127.9,
127.7, 127.2, 126.1, 124.8, 114.3, 114.0, 69.3, 55.8, 55.5, 54.5.
IR (film, ν, cm–1) 2989, 2866, 1617, 1598,
1323, 1263, 1146, 835. HR-MS (ESI) m/z calcd for C33H27ClN2NaO7S2 [M + Na]+ 685.0846, found 685.0847.

(E)-1-Butyl-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4h, Major)
136 mg, 56%; red solid, mp 168–169 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.80–7.74 (m,
2H), 7.71–7.66 (m, 2H), 7.60–7.54 (m, 3H), 7.06–7.01
(m, 2H), 6.98–6.78 (m, 1H), 6.57 (d, J = 8.8
Hz, 2H), 6.24 (s, 1H), 5.89 (s, 1H), 3.95 (s, 3H), 3.60 (s, 3H), 3.02
(s, 3H), 2.94–2.88 (m, 2H), 2.00–1.90 (m, 1H), 1.77–1.67
(m, 1H), 1.57–1.51 (m, 2H), 1.03 (d, J = 7.2
Hz, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm)
164.3, 163.3, 147.1, 147.0, 141.6, 135.8, 135.5, 132.2, 131.0, 130.8,
130.7, 128.9, 128.8, 127.7, 127.2, 127.0, 125.9, 114.5, 114.2, 113.9,
113.5, 69.2, 55.8, 55.4, 54.0, 30.5, 25.0, 23.1, 13.7. IR (film, ν,
cm–1) 2940, 2870, 1596, 1577, 1499, 1336, 1256,
1140, 836. HR-MS (ESI) m/z calcd
for C31H32N2NaO7S2 [M + Na]+ 631.1549, found 631.1552.

(E)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-8-methyl-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4i, Major)
165 mg, 63%; red solid,
mp 166–167 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.78 (d, J = 8.8 Hz, 2H), 7.62 (d, J = 8.8 Hz, 2H), 7.54–7.48 (m, 3H), 7.32 (d, J = 8.0 Hz, 3H), 7.04 (d, J = 8.4 Hz, 3H),
6.61–6.55 (m, 2H), 6.34 (s, 1H), 5.87 (s, 1H), 3.95 (s, 3H),
3.58 (s, 3H), 3.09 (s, 3H), 2.47 (s, 3H), 2.15 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.4, 148.0,
147.0, 141.1, 138.7, 138.1, 136.3, 132.8, 132.2, 131.9, 130.5, 130.4,
130.1, 130.0, 128.2, 128.1, 127.2, 126.0, 123.3, 114.3, 114.0, 68.9,
55.8, 55.4, 53.9, 21.6, 21.2. IR (film, ν, cm–1) 2950, 2843, 1595, 1577, 1496, 1335, 1255, 1148, 847. HR-MS (ESI) m/z calcd for C35H32N2NaO7S2 [M + Na]+ 679.1549,
found 679.1547.

(E)-1-(4-Chlorophenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-8-methyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4j, Major)
127 mg, 47%; red solid, mp 180–181 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.78 (d, J = 8.8 Hz, 2H), 7.64–7.58 (m, 4H), 7.54–7.50 (m, 3H),
7.34–7.31 (m, 1H), 7.07–7.00 (m, 3H), 6.59 (d, J = 8.8 Hz, 2H), 6.34 (s, 1H), 5.84 (s, 1H), 3.96 (s, 3H),
3.59 (s, 3H), 3.11 (s, 3H), 2.18 (s, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 164.3, 163.6, 148.5, 147.0, 138.3,
137.2, 137.1, 133.0, 132.2, 132.1, 132.0, 130.6, 129.7, 128.1, 127.8,
127.1, 126.1, 125.0, 114.3, 114.0, 69.0, 55.8, 55.4, 54.3, 21.3. IR
(film, ν, cm–1) 2991, 2927, 1597, 1576, 1496,
1335, 1264, 1146, 834. HR-MS (ESI) m/z calcd for C34H29ClN2NaO7S2 [M + Na]+ 699.1002, found 699.1022.

(E)-5,7-Dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4k, Major)
179 mg, 68%; red solid, mp 171–172 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.81 (d, J = 8.8 Hz, 2H), 7.65 (d, J = 9.2 Hz, 2H), 7.59–7.49
(m, 5H), 7.14–7.10 (m, 2H), 7.05 (d, J = 9.2
Hz, 2H), 6.73–6.70 (m, 1H), 6.61 (d, J = 9.2
Hz, 2H), 6.35 (s, 1H), 5.90 (s, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.61
(s, 3H), 3.09 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.5, 161.7, 147.8, 147.0, 137.8, 136.7,
136.3, 132.2, 130.6, 130.5, 130.1, 129.4, 129.3, 127.3, 126.6, 126.0,
120.6, 115.1, 114.7, 114.3, 114.0, 69.2, 55.8, 55.5, 55.5, 53.8. IR
(film, ν, cm–1) 2958, 2842, 1595, 1499, 1442,
1323, 1254, 1145, 1024, 833. HR-MS (ESI) m/z calcd for C34H30N2NaO8S2 [M + Na]+ 681.1341, found 681.1345.

(E)-5,7-Dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4l, Major)
193 mg, 72%; red solid,
mp 189–190 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.83–7.78 (m, 2H), 7.67–7.62 (m, 2H),
7.47 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.8 Hz, 1H), 7.13 (d, J = 2.8 Hz, 1H), 7.05 (d, J = 9.2 Hz, 2H),
6.75–6.71 (m, 1H), 6.61 (d, J = 9.2 Hz, 2H),
6.34 (s, 1H), 5.90 (s, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.61 (s, 3H),
3.09 (s, 3H), 2.46 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.4, 161.7, 147.6, 147.0, 140.9,
137.7, 137.0, 136.0, 132.2, 130.4, 130.2, 130.1, 129.3, 127.2, 126.0,
123.5, 120.7, 115.1, 114.7, 114.3, 114.0, 69.2, 55.8, 55.5(1), 55.5(8),
53.8, 21.6. IR (film, ν, cm–1) 2964, 2841,
1597, 1576, 1495, 1331, 1256, 1147, 1023, 836. HR-MS (ESI) m/z calcd for C35H32N2NaO8S2 [M + Na]+ 695.1498,
found 695.1500.

(E)-1-(4-Chlorophenyl)-5,7-dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4m, Major)
147 mg, 53%; red solid, mp 185–186 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.79 (d, J = 9.2 Hz, 2H), 7.63 (d, J = 8.8 Hz, 2H), 7.57–7.49
(m, 4H), 7.15–7.12 (m, 2H), 7.05 (d, J = 8.8
Hz, 2H), 6.78–6.74 (m, 1H), 6.60 (d, J = 9.2
Hz, 2H), 6.34 (s, 1H), 5.86 (s, 1H), 3.96 (s, 3H), 3.89 (s, 3H), 3.59
(s, 3H), 3.10 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.6, 161.9, 148.1, 147.0, 138.0, 137.0,
136.8, 135.3, 132.2, 132.0, 129.8, 129.3, 127.1, 126.1, 125.1, 120.2,
115.4, 114.7, 114.3, 114.0, 69.3, 55.8, 55.6, 55.5, 54.1. IR (film,
ν, cm–1) 2948, 2938, 1596, 1577, 1497, 1332,
1257, 1148, 837. HR-MS (ESI) m/z calcd for C34H29ClN2NaO8S2 [M + Na]+ 715.0952, found 715.0957.

(E)-7-Chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4n, Major)
119 mg, 45%; red solid, mp 177–178 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.80 (d, J = 8.8 Hz, 2H), 7.66–7.62 (m, 3H), 7.61–7.52 (m, 5H),
7.18–7.12 (m, 2H), 7.06 (d, J = 8.8 Hz, 2H),
6.62 (d, J = 8.8 Hz, 2H), 6.34 (s, 1H), 5.87 (s,
1H), 3.97 (s, 3H), 3.61 (s, 3H), 3.14 (s, 3H). 13C NMR
(100 MHz, CDCl3; δ, ppm) 164.4, 163.7, 147.8, 147.0,
139.1, 137.6, 137.2, 135.5, 132.2, 130.9, 130.6, 130.5, 129.5, 128.9,
128.7, 127.2, 126.6, 126.1(3), 126.1(7), 114.4, 114.1, 69.0, 55.8,
55.5, 54.6. IR (film, ν, cm–1) 2940, 1842,
1616, 1593, 1497, 1263, 1145, 837. HR-MS (ESI) m/z calcd for C33H27ClN2NaO7S2 [M + Na]+ 685.0846, found 685.0842.

(E)-7-Chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4o, Major)
130 mg, 48%; red solid,
mp 225–226 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 8.43 (d, J = 2.0 Hz, 1H), 7.91 (d, J = 8.8 Hz, 2H), 7.62 (d, J = 9.2 Hz, 3H),
7.36 (s, 1H), 7.32–7.22 (m, 3H), 7.11 (d, J = 8.8 Hz, 3H), 6.81 (d, J = 8.8 Hz, 3H), 6.30 (s,
1H), 4.24 (s, 3H), 3.98 (s, 3H), 3.84 (s, 3H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.6, 163.0,
153.5, 147.0, 140.1, 137.4, 134.4, 132.2, 131.9, 131.7, 131.0, 130.4,
129.8, 129.1, 128.7, 128.5, 127.9, 125.0, 124.9, 123.7, 119.1, 114.5,
114.1, 80.0, 69.1, 64.9, 55.8, 21.4. IR (film, ν, cm–1) 2960, 2835, 1637, 1616, 1593, 1500, 1338, 1257, 1145, 834. HR-MS
(ESI) m/z calcd for C34H29ClN2NaO7S2 [M + Na]+ 699.1002, found 699.1003.

(E)-7-Chloro-1-(4-ethylphenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4p, Major)
152 mg, 55%; red solid, mp 177–178 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.79 (d, J = 9.2 Hz, 2H), 7.64 (d, J = 9.2 Hz, 3H), 7.51 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H),
7.23–7.15 (m, 2H), 7.05 (d, J = 8.8 Hz, 2H),
6.61 (d, J = 9.2 Hz, 2H), 6.33 (s, 1H), 5.87 (s,
1H), 3.97 (s, 3H), 3.61 (s, 3H), 3.13 (s, 3H), 2.79–2.73 (m,
2H), 1.32 (t, J = 7.6 Hz, 3H). 13C NMR
(100 MHz, CDCl3; δ, ppm) 164.3, 163.6, 147.6, 147.5,
146.9, 139.4, 137.5, 137.1, 135.1, 132.2, 130.6, 130.3, 129.7, 129.1,
128.9, 128.7, 127.2, 126.8, 126.1, 123.1, 114.3, 114.0, 69.0, 55.8,
55.5, 54.5, 28.9, 15.2. IR (film, ν, cm–1)
2964, 2833, 1594, 1497, 1332, 1320, 1145, 1083, 832. HR-MS (ESI) m/z calcd for C35H31ClN2NaO7S2 [M + Na]+ 713.1159,
found 713.1158.

(E)-1-(4-(tert-Butyl)phenyl)-7-chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4q, Major)
155 mg, 54%; red solid, mp 166–167 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.80 (d, J = 9.2 Hz, 2H), 7.67–7.61 (m, 3H), 7.53 (s, 4H), 7.23–7.17
(m, 2H), 7.06 (d, J = 9.2 Hz, 2H), 6.62 (d, J = 9.2 Hz, 2H), 6.33 (s, 1H), 5.88 (s, 1H), 3.97 (s, 3H),
3.62 (s, 3H), 3.14 (s, 3H), 1.39 (s, 9H). 13C NMR (100
MHz, CDCl3; δ, ppm) 164.3, 163.6, 154.5, 147.5, 147.0,
139.4, 137.5, 137.1, 135.1, 132.2, 130.6, 130.1, 129.7, 128.9, 128.7,
127.3, 126.8, 126.5, 126.1, 122.9, 114.3, 114.0, 69.0, 55.8, 55.5,
54.5, 35.0, 31.2. IR (film, ν, cm–1) 2953,
2841, 1595, 1501, 1458, 1336, 1263, 1145, 1083, 832. HR-MS (ESI) m/z calcd for C37H35ClN2NaO7S2 [M + Na]+ 741.1472,
found 741.1471.

(E)-7-Chloro-5-methoxy-1-(4-methoxyphenyl)-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4r, Major)
169 mg, 61%; red solid, mp 179–180 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.78 (d, J = 8.8 Hz, 2H), 7.65–7.60 (m, 3H), 7.56 (d, J = 8.8 Hz, 2H), 7.25 (d, J = 8.4 Hz, 1H), 7.21–7.17
(m, 1H), 7.07–7.02 (m, 4H), 6.60 (d, J = 8.8
Hz, 2H), 6.32 (s, 1H), 5.86 (s, 1H), 3.96 (s, 3H), 3.90 (s, 3H), 3.59
(s, 3H), 3.14 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 163.6, 161.8, 147.4, 146.9, 139.1, 137.6,
137.0, 134.7, 132.2, 132.0, 130.6, 129.7, 128.8, 128.6, 127.2, 126.9,
126.1, 117.8, 115.1, 114.3, 114.0, 69.0, 55.8, 55.5, 54.6. IR (film,
ν, cm–1) 2947, 2839, 1597, 1577, 1496, 1332,
1256, 1166, 837. HR-MS (ESI) m/z calcd for C34H29ClN2NaO8S2 [M + Na]+ 715.0952, found 715.0961.

(E)-4-((4-Ethoxyphenyl)diazenyl)-3-((4-ethoxyphenyl)sulfonyl)-5-methoxy-1-phenyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4s, Major)
136 mg, 52%; red solid, mp 180–181 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.79 (d, J = 8.8 Hz, 2H), 7.65–7.59 (m, 5H), 7.56–7.47 (m, 4H),
7.22–7.15 (m, 2H), 7.03 (d, J = 8.8 Hz, 2H),
6.57 (d, J = 8.8 Hz, 2H), 6.36 (s, 1H), 5.92 (s,
1H), 4.22–4.16 (m, 2H), 3.86–3.79 (m, 1H), 3.70–3.62
(m, 1H), 3.12 (s, 3H), 1.52 (t, J = 7.0 Hz, 3H),
1.34 (t, J = 7.0 Hz, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 163.8, 163.0, 148.1, 146.9, 138.7,
136.5, 135.8, 132.2, 131.1, 130.7(1), 130.7(6), 130.6, 129.8, 129.4,
128.2(4), 128.2(8), 127.7, 126.9, 126.4, 126.1, 114.7, 114.5, 114.4,
69.2, 64.1, 63.9, 54.2, 14.7, 14.4. IR (film, ν, cm–1) 2978, 2933, 1593, 1574, 1494, 1321, 1254, 1145, 835. HR-MS (ESI) m/z calcd for C35H32N2NaO7S2 [M + Na]+ 679.1549,
found 679.1554.

(E)-4-((4-Ethoxyphenyl)diazenyl)-3-((4-ethoxyphenyl)sulfonyl)-5-methoxy-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4t, Major)
153 mg, 57%; red solid,
mp 184–185 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.81–7.76 (m, 2H), 7.65–7.59 (m, 3H),
7.51–7.46 (m, 3H), 7.34–7.31 (m, 2H), 7.26 (d, J = 7.2 Hz, 1H), 7.22–7.16 (m, 1H), 7.05–7.01
(m, 2H), 6.55–6.58 (m, 2H), 6.34 (s, 1H), 5.92 (s, 1H), 4.22–4.16
(m, 2H), 3.86–3.78 (m, 1H), 3.70–3.63 (m, 1H), 3.11
(s, 3H), 2.46 (s, 3H), 1.52 (t, J = 7.0 Hz, 3H),
1.35 (t, J = 7.0 Hz, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 163.8, 162.9, 147.9, 146.9, 141.1,
140.0, 136.1, 135.7, 132.2, 131.0, 130.6, 130.4, 130.1, 129.9, 128.3,
128.2, 127.7, 126.9, 126.1, 123.3, 114.7, 114.4, 69.2, 64.1, 63.9,
54.1, 21.6, 14.7, 14.4. IR (film, ν, cm–1)
2981, 2931, 1599, 1574, 1494, 1322, 1254, 1146, 835. HR-MS (ESI) m/z calcd for C36H34N2NaO7S2 [M + Na]+ 693.1705,
found 693.1708.

(E)-4-((3,4-Dimethoxyphenyl)diazenyl)-3-((3,4-dimethoxyphenyl)sulfonyl)-5-methoxy-1-(p-tolyl)-3,5-dihydronaphtho[1,2-c]thiophene
2,2-dioxide (4u, Major)
174 mg, 62%; red solid,
mp 187–188 °C; 1H NMR (400 MHz, CDCl3; δ, ppm) 7.63–7.59 (m, 2H), 7.46–7.44 (m, 3H),
7.40 (d, J = 2.0 Hz, 1H), 7.32 (s, 1H), 7.30 (s,
1H), 7.25–7.16 (m, 3H), 7.04 (d, J = 8.4 Hz,
1H), 6.96 (d, J = 2.4 Hz, 1H), 6.51 (d, J = 8.8 Hz, 1H), 6.39 (s, 1H), 5.94 (s, 1H), 4.05 (s, 3H), 4.04 (s,
3H), 3.68 (s, 3H), 3.44 (s, 3H), 3.13 (s, 3H), 2.46 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 154.0, 153.5,
149.7, 148.6, 148.0, 147.2, 141.3, 139.1, 135.9, 135.6, 131.0, 130.6,
130.3, 130.2, 130.0, 128.5, 128.4, 127.7, 126.9, 124.9, 123.1, 122.5,
111.8, 110.4, 110.2, 102.9, 69.2, 56.3, 56.2, 56.0, 55.8, 54.2, 21.6.
IR (film, ν, cm–1) 2964, 2839, 1596, 1500,
1332, 1263, 1145, 1024, 832. HR-MS (ESI) m/z calcd for C36H34N2NaO9S2 [M + Na]+ 725.1603, found 725.1601.

(E)-1-(4-Chlorophenyl)-5,7-dimethoxy-4-(p-tolyldiazenyl)-3-tosyl-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4v, Major)
129 mg, 49%; red solid, mp 184–185 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.70 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 8.4 Hz, 2H), 7.57–7.50
(m, 4H), 7.36 (d, J = 8.0 Hz, 2H), 7.16–7.13
(m, 2H), 6.96 (d, J = 8.0 Hz, 2H), 6.79–6.75
(m, 1H), 6.37 (s, 1H), 5.86 (s, 1H), 3.90 (s, 3H), 3.11 (s, 3H), 2.51
(s, 3H), 2.15 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 161.9, 150.6, 148.1, 145.9, 143.7, 138.0, 137.1,
136.7, 135.7, 133.0, 132.0, 130.7, 129.9, 129.8(2), 129.8(8), 129.5,
129.3, 125.0, 123.9, 120.1, 115.4, 114.8, 69.3, 55.6, 54.2, 21.7,
21.5. IR (film, ν, cm–1) 2969, 2862, 1598,
1483, 1334, 1326, 1170, 1090, 827. HR-MS (ESI) m/z calcd for C34H29ClN2NaO6S2 [M + Na]+ 683.1053, found 683.1055.

(E)-1-(4-Ethylphenyl)-5-methoxy-4-(phenyldiazenyl)-3-(phenylsulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4w, Major)
102 mg, 43%; red solid, mp 162–163 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.89–7.84 (m,
2H), 7.82–7.78 (m, 2H), 7.64 (d, J = 7.6 Hz,
1H), 7.59–7.56 (m, 3H), 7.53–7.46 (m, 3H), 7.38–7.33
(m, 3H), 7.25–7.19 (m, 4H), 6.44 (s, 1H), 5.96 (s, 1H), 3.17
(s, 3H), 2.79–2.73 (m, 2H), 1.32 (t, J = 7.6
Hz, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm)
152.6, 148.3, 147.5, 139.6, 136.3, 136.0, 135.7, 134.5, 132.5, 131.2,
131.1, 130.7, 130.3, 130.1, 129.2, 129.0, 128.7, 128.3, 128.0, 127.8,
123.8, 123.2, 69.4, 54.5, 28.9, 15.2. IR (film, ν, cm–1) 2943, 2821, 1613, 1582, 1447, 1343, 1161, 1076, 776. HR-MS (ESI) m/z calcd for C33H28N2NaO5S2 [M + Na]+ 619.1337,
found 619.1335.

(E)-5,7-Dimethoxy-1-phenyl-4-(phenyldiazenyl)-3-(phenylsulfonyl)-3,5-dihydronaphtho[1,2-c]thiophene 2,2-dioxide (4y, Major)
115 mg, 48%; red solid, mp 163–164 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.88–7.84 (m,
2H), 7.80 (d, J = 8.0 Hz, 2H), 7.60–7.56 (m,
3H), 7.55–7.49 (m, 5H), 7.41–7.36 (m, 1H), 7.25–7.19
(m, 2H), 7.15 (d, J = 2.8 Hz, 1H), 7.08 (d, J = 8.8 Hz, 1H), 6.74–6.70 (m, 1H), 6.45 (s, 1H),
5.94 (s, 1H), 3.88 (s, 3H), 3.14 (s, 3H). 13C NMR (100
MHz, CDCl3; δ, ppm) 161.8, 152.6, 148.1, 137.8, 137.3,
136.3, 136.2, 134.5, 132.6, 131.4, 130.7, 130.5, 130.1, 129.4(1),
129.4(6), 129.2, 128.7, 126.4, 123.8, 123.6, 120.2, 115.2, 114.8,
69.3, 55.5, 54.1. IR (film, ν, cm–1) 3063,
2965, 1612, 1581, 1446, 1327, 1172, 1079, 780. HR-MS (ESI) m/z calcd for C32H26N2NaO6S2 [M + Na]+ 621.1130,
found 621.1125.

(E)-4-((4-Methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-2,2-dioxido-1-phenyl-3,5-dihydronaphtho[1,2-c]thiophen-5-yl acetate (4z, Major)
144 mg, 55%; red solid, mp 178–179 °C; 1H
NMR (400 MHz, CDCl3; δ, ppm) 7.83 (d, J = 7.6 Hz, 1H), 7.68 (d, J = 8.8 Hz, 1H), 7.58–7.51
(m, 4H), 7.49–7.39 (m, 6H), 7.23–7.18 (m, 1H), 7.04–6.99
(m, 2H), 6.75 (d, J = 8.4 Hz, 1H), 6.55 (d, J = 8.8 Hz, 1H), 6.40 (s, 1H), 6.21 (s, 1H), 3.96 (s, 3H),
3.66 (s, 3H), 3.59 (s, 3H). 13C NMR (100 MHz, CDCl3; δ, ppm) 164.3, 164.1, 163.7, 146.3, 143.8, 138.2,
136.9, 132.2, 131.8, 131.7, 130.8, 130.7, 130.5, 129.4, 129.2, 128.9,
128.6, 127.5, 127.3, 127.1, 126.2, 126.0, 114.5, 114.2, 114.0, 65.0,
55.8, 55.5(1), 55.5(7). IR (film, ν, cm–1)
2933, 2840, 1637, 1617, 1594, 1496, 1320, 1263, 1144, 835. HR-MS (ESI) m/z calcd for C34H28N2NaO8S2 [M + Na]+ 679.1185,
found 679.1182.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b01789.X-ray crystal
data (CIF) for 4a (PDF)

Crystallographic data (CIF)



Supplementary Material
ao7b01789_si_001.pdf

 ao7b01789_si_002.cif

 The authors
declare no competing financial interest.

Acknowledgments
We are
grateful for financial support from the NSFC (Nos.
216020872 and 1472071), PAPD of Jiangsu Higher Education Institutions,
the Outstanding Youth Fund of JSNU (YQ2015003), NSF of Jiangsu Province
(BK20151163 and BK20160212), and the Qing Lan Project of Jiangsu Education
Committee.
==== Refs
References
a Harrak Y. ; Casula G. ; Basset J. ; Rosell G. ; Plescia S. ; Raffa D. ; Cusimano M. G. ; Pouplana R. ; Pujol M. D. 
Synthesis, anti-inflammatory
activity, and in vitro
antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(Aryloyl)phenyl
methyl sulfones . J. Med. Chem. 
2010 , 53 , 6560 –6571 . 10.1021/jm100398z .20804197  b Smith D. A. ; Jones R. M. 
The sulfonamide group as a structural alert: a distorted
story . Curr. Opin. Drug Discovery Dev. 
2008 , 11 , 72 –79 . c Noutoshi Y. ; Ikeda M. ; Saito T. ; Osada H. ; Shirasu K. 
Sulfonamides identified as plant immune-priming compounds
in high-throughput chemical screening increase disease resistance
in Arabidopsis thaliana . Front. Plant Sci. 
2012 , 3 , 24510.3389/fpls.2012.00245 .23118736  d Drews J. 
Drug discovery: A historical perspective . Science 
2000 , 287 , 1960 –1963 . 10.1126/science.287.5460.1960 .10720314 
a Valente C. ; Guedes R. C. ; Moreia R. ; Iley J. ; Gut J. ; Rosenthal P. J. 
Dipeptide
vinyl sultams: Synthesis via the Wittig-Horner
reaction and activity against papain, falcipain-2 and Plasmodium falciparum . Bioorg.
Med. Chem. Lett. 
2006 , 16 , 4115 –4119 . 10.1016/j.bmcl.2006.04.079 .16697641  b Zhuang L. ; Wai J. S. ; Embrey M. W. ; Fisher T. E. ; Egbertson M. S. ; Payne L. S. ; Guare J. P. ; Vacca J. P. ; Hazuda D. J. ; Felock P. J. ; Wolfe A. L. ; Stilmock K. A. ; Witmer M. V. ; Moyer G. ; Schleif W. A. ; Gabryelski L. J. ; Leonard Y. M. ; Lynch J. J. ; Michelson S. R. ; Young S. D. 
Design and synthesis of 8-hydroxy-[1,6]naphthyridines
as novel inhibitors of HIV-1 integrase in vitro and in infected cells . J. Med. Chem. 
2003 , 46 , 453 –456 . 10.1021/jm025553u .12570367  c Misu Y. ; Togo H. 
Novel preparation of 2,1-benzothiazine
derivatives from sulfonamides with [hydroxy(tosyloxy)iodo]arenes . Org. Biomol. Chem. 
2003 , 1 , 1342 –1346 . 10.1039/b301330h .12929664  d Ahn K. H. ; Kim S. K. ; Ham C. 
Evaluation
of chiral benzosultams as auxiliaries in asymmetric azidation reactions . Tetrahedron Lett. 
1998 , 39 , 6321 –6322 . 10.1016/S0040-4039(98)01341-0 . e Wells G. J. ; Tao M. ; Josef K. A. ; Bihovsky R. 
1,2-Benzothiazine 1,1-dioxide p2-p3
peptide mimetic aldehyde calpain I inhibitors . J. Med. Chem. 
2001 , 44 , 3488 –3503 . 10.1021/jm010178b .11585453 
a Chen S. ; Yang Y. ; Wu Y. ; Tian H. ; Zhu W. 
Multi-addressable photochromic terarylene
containing benzo[b]thiophene-1,1-dioxide unit as
ethene bridge: multifunctional
molecular logic gates on unimolecular platform . J. Mater. Chem. 
2012 , 22 , 5486 –5494 . 10.1039/c2jm14973g . b Chen S. ; Chen L.-J. ; Yang H.-B. ; Tian H. ; Zhu W. 
Light-triggered reversible supramolecular transformations of multi-bisthienylethene
hexagons . J. Am. Chem. Soc. 
2012 , 134 , 13596 –13599 . 10.1021/ja306748k .22881042 
a Kim S. H. ; Tran M. T. ; Ruebsam F. ; Xiang A. X. ; Ayida B. ; McGuire H. ; Ellis D. ; Blazel J. ; Tran C. V. ; Murphy D. E. ; Webber S. E. ; Zhou Y. ; et al. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole
and benzo[b]thiophene-1,1-dioxide derivatives as
novel inhibitors of hepatitis C virus NS5B polymerase . Bioorg. Med. Chem. Lett. 
2008 , 18 , 4181 –4185 . 10.1016/j.bmcl.2008.05.083 .18554907  b Innocenti A. ; Villar R. ; Martinez-Merino V. ; Gil M. J. ; Scozzafava A. ; Vullo D. ; Supuran C. T. 
Carbonic anhydrase inhibitors: inhibition
of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and
IX with benzo[b]thiophene 1,1-dioxide sulfonamides . Bioorg. Med. Chem. Lett. 
2005 , 15 , 4872 –4876 . 10.1016/j.bmcl.2005.04.078 .16165351  c Villar R. ; Encio I. ; Migliaccio M. ; Gil M. J. ; Martinez-Merino V. 
Synthesis
and cytotoxic activity of lipophilic sulphonamide derivatives of the
benzo[b]thiophene 1,1-dioxide . Bioorg. Med. Chem. 
2004 , 12 , 963 –968 . 10.1016/j.bmc.2003.12.012 .14980609 
a Grigg R. ; Scott R. ; Stevenson P. 
Rhodium-catalysed
[2 + 2 + 2] cycloadditions of acetylenes . J.
Chem. Soc., Perkin Trans. 1 
1988 , 1357 –1364 . 10.1039/P19880001357 . b Tahara Y.-K. ; Gake M. ; Matsubara R. ; Shibata T. 
Catalytic [2 + 2 + 2] cycloaddition of benzothiophene
dioxides with α,ω-diynes for the synthesis of condensed
polycyclic compounds . Org. Lett. 
2014 , 16 , 5980 –5983 . 10.1021/ol5030019 .25384066 
a Charlton J. L. ; Durst T. 
Photochemical synthesis of α-oxygenated
benzothiophenedioxides . Tetrahedron Lett. 
1984 , 25 , 2663 –2666 . 10.1016/S0040-4039(01)81257-0 . b Charlton J. L. ; Koh K. 
Substituent effects on the photochemistry
of o-tolualdehydes . Tetrahedron
Lett. 
1988 , 29 , 5595 –5598 . 10.1016/S0040-4039(00)80821-7 .
a Zafrani Y. ; Gottlieb H. E. ; Sprecher M. ; Braverman S. 
Sequential
intermediates in the base-catalyzed conversion of bis(π-conjugated
propargyl) sulfones to 1,3-dihydrobenzo- and naphtho[c]thiophene-2,2-dioxides . J. Org. Chem. 
2005 , 70 , 10166 –10168 . 10.1021/jo051692i .16292864  b Braverman S. ; Zafrani Y. ; Gottlieb H. E. 
Base catalyzed
rearrangement of π-conjugated sulfur and selenium bridged propargylic
systems . Tetrahedron 
2001 , 57 , 9177 –9185 . 10.1016/S0040-4020(01)00923-1 . c Maji M. ; Mallick D. ; Mondal S. ; Anoop A. ; Bag S. S. ; Basak A. ; Jemmis E. D. 
Selectivity in Garratt-Braverman
cyclization: An experimental and computational study . Org. Lett. 
2011 , 13 , 888 –891 . 10.1021/ol102861j .21302895  d Basak A. ; Das S. ; Mallick D. ; Jemmis E. D. 
Which one
is preferred: Myers-Saito cyclization of ene-yne-allene or Garratt-Braverman
cyclization of conjugated bisallenic sulfone? A theoretical and experimental
study . J. Am. Chem. Soc. 
2009 , 131 , 15695 –15704 . 10.1021/ja9023644 .19824673  e Zafrani Y. ; Cherkinsky M. ; Gottlieb H. E. ; Braverman S. 
A new approach
to the synthesis of 2-vinylthiophenes and selenophenes; competition
between free radical and anionic cycloaromatization of bridged di-
and tetrapropargylic sulfides and selenides . Tetrahedron 
2003 , 59 , 2641 –2649 . 10.1016/S0040-4020(03)00327-2 . f Mukherjee R. ; Mondal S. ; Basak A. ; Mallick D. ; Jemmis E. D. 
Reactivity of bispropargyl sulfones under basic conditions:
Interplay between Garratt-Braverman and Schmittel/Myers-Saito cyclization
pathway . Chem. - Asian J. 
2012 , 7 , 957 –965 . 10.1002/asia.201100903 .22407821  g Mitra T. ; Das J. ; Maji M. ; Das R. ; Das U. K. ; Chattaraj P. K. ; Basak A. 
A one-pot Garratt-Braverman cyclization and Scholl oxidation route
to acene-helicene hybrids . RSC Adv. 
2013 , 3 , 19844 –19848 . 10.1039/c3ra42696c . h Ghosh D. ; Biswas S. ; Ghosh K. ; Basak A. 
Garratt-Braverman cyclization
on basic alumina: a green protocol with improved selectivity . Tetrahedron Lett. 
2014 , 55 , 3934 –3937 . 10.1016/j.tetlet.2014.05.033 . i Das J. ; Bag S. S. ; Basak A. 
Mechanistic
studies on Garratt-Braverman cyclization: The diradical-cycloaddition
puzzle . J. Org. Chem. 
2016 , 81 , 4623 –4632 . 10.1021/acs.joc.6b00490 .27116541 
a Babu S. D. ; Hrytsak M. D. ; Durst T. 
Intramolecular rhodium
carbenoid insertions into aromatic C-H bonds. Preparation of 1,3-dihydrothiophene
2,2-dioxides fused onto aromatic rings . Can.
J. Chem. 
1989 , 67 , 1071 –1076 . 10.1139/v89-162 . b Hrytsak M. ; Etkin N. ; Durst T. 
Intramolecular rhodium
carbenoid insertions into aromatic C-H bonds. Preparation of 1-carboalkoxy-1,3-dihydrobenzo[c]thiophene 2,2-dioxides . Tetrahedron
Lett. 
1986 , 27 , 5679 –5682 . 10.1016/S0040-4039(00)85299-5 .
Ciufolini M. A. ; Qi H. B. ; Browne M. E. 
Intramolecular
arylations of soft
enolates catalyzed by zerovalent palladium . J. Org. Chem. 
1988 , 53 , 4149 –4151 . 10.1021/jo00252a064 .
a Luo Y. ; Pan X.-L. ; Chen C. ; Yao L.-Q. ; Wu J. 
An unexpected reaction of 2-alkynylaryldiazonium
tetrafluoroborate with sulfur dioxide . Chem.
Commun. 
2015 , 51 , 180 –182 . 10.1039/C4CC07938H . b Mao R.-Y. ; Zheng D.-Q. ; Xia H.-G. ; Wu J. 
Copper(I)-catalyzed
sulfonylation of (2-alkynylaryl)boronic acids with DABSO . Org. Chem. Front. 
2016 , 3 , 693 –696 . 10.1039/C6QO00070C .
Emmett E. J. ; Willis M. C. 
The development
and application of sulfur dioxide surrogates
in synthetic organic chemistry . Asian J. Org.
Chem. 
2015 , 4 , 602 –611 . 10.1002/ajoc.201500103 .
a Woolven H. ; González-Rodríguez C. ; Marco I. ; Thompson A. L. ; Willis M. C. 
DABCO-Bis(sulfur
dioxide), DABSO, as a convenient source of sulfur dioxide for organic
synthesis: Utility in sulfonamide and sulfamide preparation . Org. Lett. 
2011 , 13 , 4876 –4878 . 10.1021/ol201957n .21866926  b Deeming A. S. ; Russell C. J. ; Willis M. C. 
Palladium(II)-catalyzed
synthesis of sulfinates from boronic acids and DABSO: A redox-neutral,
phosphine-free transformation . Angew. Chem.,
Int. Ed. 
2016 , 55 , 747 –750 . 10.1002/anie.201508370 . c Lenstra D. C. ; Vedovato V. ; Flegeau E. F. ; Maydom J. ; Willis M. C. 
One-pot sulfoxide synthesis exploiting a sulfinyl-dication
equivalent generated from a DABSO/trimethylsilyl chloride sequence . Org. Lett. 
2016 , 18 , 2086 –2089 . 10.1021/acs.orglett.6b00712 .27082825  d Deeming A. S. ; Russell C. J. ; Willis M. C. 
Combining organometallic
reagents, the sulfur dioxide surrogate DABSO, and amines: A one-pot
preparation of sulfonamides, amenable to array synthesis . Angew. Chem., Int. Ed. 
2015 , 54 , 1168 –1171 . 10.1002/anie.201409283 . e Emmett E. J. ; Hayter B. R. ; Willis M. C. 
Palladium-catalyzed synthesis of ammonium sulfinates
from aryl halides and a sulfur dioxide surrogate: A gas- and reductant-free
process . Angew. Chem., Int. Ed. 
2014 , 53 , 10204 –10208 . 10.1002/anie.201404527 . f Emmett E. J. ; Hayter B. R. ; Willis M. C. 
Palladium-catalyzed
three-component diaryl sulfone synthesis exploiting the sulfur dioxide
surrogate DABSO . Angew. Chem. 
2013 , 125 , 12911 –12915 . 10.1002/ange.201305369 .
a Tsai A. S. ; Curto J. M. ; Rocke B. N. ; Dechert-Schmitt A.-M. R. ; Ingle G. K. ; Mascitti V. 
One-step synthesis
of sulfonamides from N-tosylhydrazones . Org. Lett. 
2016 , 18 , 508 –511 . 10.1021/acs.orglett.5b03545 .26771228  b Liu T. ; Zheng D. ; Ding Y. ; Fan X. ; Wu J. 
Synthesis of β-keto sulfones by a catalyst-free reaction of
aryldiazonium tetrafluoroborates, sulfur dioxide, and silyl enol ethers . Chem. - Asian J. 
2017 , 12 , 465 –469 . 10.1002/asia.201601617 .28052596  c Xiang Y.-C. ; Kuang Y.-Y. ; Wu J. 
Generation of β-halo
vinylsulfones through a multicomponent reaction with insertion of
sulfur dioxide . Chem. - Eur. J. 
2017 , 23 , 6996 –6999 . 10.1002/chem.201701465 .28374924  d Zhou K. ; Xia H. ; Wu J. 
Generation of benzosultams
via radical process with the insertion of sulfur dioxide . Org. Chem. Front. 
2017 , 4 , 1121 –1124 . 10.1039/C7QO00127D . e Waldmann C. ; Schober O. ; Haufe G. ; Kopka K. 
A closer look at the bromine-lithium exchange with tert-butyllithium
in an aryl sulfonamide synthesis . Org. Lett. 
2013 , 15 , 2954 –2957 . 10.1021/ol4010454 .23734872  f Wang X. ; Xue L.-J. ; Wang Z.-Y. 
A copper-catalyzed
three-component reaction of triethoxysilanes, sulfur dioxide, and
hydrazines . Org. Lett. 
2014 , 16 , 4056 –4058 . 10.1021/ol5018849 .25032787  g Chen C. C. ; Waser J. 
One-pot, three-component arylalkynyl sulfone synthesis . Org. Lett. 
2015 , 17 , 736 –739 . 10.1021/acs.orglett.5b00015 .25633719 
a Zheng D. ; Yu J. ; Wu J. 
Generation
of sulfonyl radicals from aryldiazonium tetrafluoroborates and sulfur
dioxide: the synthesis of 3-sulfonated coumarins . Angew. Chem., Int. Ed. 
2016 , 55 , 11925 –11929 . 10.1002/anie.201607292 . b Qiu G. ; Zhou K. ; Gao L. ; Wu J. 
Insertion of sulfur dioxide via a radical process: an efficient route
to sulfonyl compounds . Org. Chem. Front. 
2018 , 10.1039/C7QO01073G .
a Liu F. ; Wang J.-Y. ; Zhou P. ; Li G. ; Hao W.-J. ; Tu S.-J. ; Jiang B. 
Merging [2+2] cycloaddition
with radical 1,4-addition: metal-free access to functionalized cyclobuta[a]naphthalen-4-ols . Angew. Chem.,
Int. Ed. 
2017 , 56 , 15570 –15574 . 10.1002/anie.201707615 . b Huang M.-H. ; Zhu Y.-L. ; Hao W.-J. ; Wang A.-F. ; Wang D.-C. ; Liu F. ; Wei P. ; Tu S.-J. ; Jiang B. 
Visible-light photocatalytic bicyclization of 1,7-enynes toward functionalized
sulfone-containing benzo[a]fluoren-5-ones . Adv.
Synth. Catal. 
2017 , 359 , 2229 –2234 . 10.1002/adsc.201700124 . c Hao W.-J. ; Du Y. ; Wang D. ; Jiang B. ; Gao Q. ; Tu S.-J. ; Li G. 
Catalytic diazosulfonylation of enynals
toward diazoindenes via oxidative radical-triggered 5-exo-trig carbocyclizations . Org. Lett. 
2016 , 18 , 1884 –1887 . 10.1021/acs.orglett.6b00655 .27028216  d Zhu Y.-L. ; Jiang B. ; Hao W.-J. ; Wang A.-F. ; Qiu J.-K. ; Wei P. ; Wang D.-C. ; Li G. ; Tu S.-J. 
A new cascade halosulfonylation of 1,7-enynes toward 3,4-dihydroquinolin-2(1H)-ones
via sulfonyl radical-triggered addition/6-exo-dig cyclization . Chem. Commun. 
2016 , 52 , 1907 –1910 . 10.1039/C5CC08895J . e Shen Z.-J. ; Wu Y.-N. ; He C.-L. ; He L. ; Hao W.-J. ; Wang A.-F. ; Tu S.-J. ; Jiang B. 
Stereoselective
synthesis of sulfonated 1-indenones via radical-triggered multi-component
cyclization of β-alkynyl propenones . Chem.
Commun. 
2018 , 54 , 445 –448 . 10.1039/C7CC08516H .
Wang A.-F. ; Zhou P. ; Zhu Y.-L. ; Hao W.-J. ; Li G. ; Tu S.-J. ; Jiang B. 
Metal-free
benzannulation of 1,7-diynes
toward unexpected 1-aroyl-2-naphthaldehydes and their application
in fused aza-heterocyclic synthesis . Chem. Commun. 
2017 , 53 , 3369 –3372 . 10.1039/C7CC00323D .
Jiang H. ; Chen Y. ; Chen B. ; Xu H. ; Wan W. ; Deng H. ; Ma K. ; Wu S. ; Hao J. 
Ag-initiated
gem-difluoromethylenation of the nitrogen center of arenediazonium
salts to gem-difluoromethylene azo compounds . Org. Lett. 
2017 , 19 , 2406 –2409 . 10.1021/acs.orglett.7b00936 .28430453 
Eugène F. ; Langlois B. ; Laurent E. 
N-Ethyldiisopropylamine
and sulfur dioxide solutions. 2. Reactions with conjugate acceptors . J. Org. Chem. 
1994 , 59 , 2599 –2603 . 10.1021/jo00088a051 .
a Yang D. ; Huang B. ; Wei W. ; Li J. ; Lin G. ; Liu Y. ; Ding J. ; Sun P. ; Wang H. 
Visible-light
initiated direct oxysulfonylation of alkenes with sulfinic
acids leading to β-ketosulfones . Green
Chem. 
2016 , 18 , 5630 –5634 . 10.1039/C6GC01403H . b Wen J. ; Wei W. ; Xue S. ; Yang D. ; Lou Y. ; Gao C. ; Wang H. 
Metal-Free oxidative spirocyclization
of alkynes with sulfonylhydrazides leading to 3-sulfonated azaspiro[4,5]trienones . J. Org. Chem. 
2015 , 80 , 4966 –4972 . 10.1021/acs.joc.5b00361 .25928832  c Wei W. ; Wen J. ; Yang D. ; Guo M. ; Wang Y. ; You J. ; Wang H. 
Direct and metal-free
arylsulfonylation of alkynes with sulfonylhydrazides for the construction
of 3-sulfonated coumarins . Chem. Commun. 
2015 , 51 , 768 –771 . 10.1039/C4CC08117J . d Wei W. ; Wen J. ; Yang D. ; Du J. ; You J. ; Wang H. 
Catalyst-free direct arylsulfonylation of N-arylacrylamides with
sulfinic acids: a convenient and efficient route to sulfonated oxindoles . Green Chem. 
2014 , 16 , 2988 –2991 . 10.1039/C4GC00231H .
a Qiu J.-K. ; Jiang B. ; Zhu Y.-L. ; Hao W.-J. ; Wang D.-C. ; Sun J. ; Wei P. ; Tu S.-J. ; Li G. 
Catalytic dual 1,1-H-abstraction/insertion
for domino spirocyclizations . J. Am. Chem. Soc. 
2015 , 137 , 8928 –8931 . 10.1021/jacs.5b05735 .26131954  b Jiang B. ; Li J. ; Pan Y.-Y. ; Hao W.-J. ; Li G. ; Tu S.-J. 
Radical-enabled bicyclization cascades of oxygen-tethered
1,7-enynes leading to skeletally diverse polycyclic chromen-2-ones . Chin. J. Chem. 
2017 , 35 , 323 –334 . 10.1002/cjoc.201600571 . c Li J. ; Zhang W.-W. ; Wei X.-J. ; Liu F. ; Hao W.-J. ; Wang S.-L. ; Li G. ; Tu S.-J. ; Jiang B. 
Radical deaminative ipso-cyclization of 4-methoxyanilines
with 1,7-enynes for accessing spirocyclohexadienone-containing cyclopenta[c]quinolin-4-ones . J. Org. Chem. 
2017 , 82 , 6621 –6628 . 10.1021/acs.joc.7b00704 .28594176  d Sun J. ; Qiu J.-K. ; Wu Y.-N. ; Hao W.-J. ; Guo C. ; Li G. ; Tu S.-J. ; Jiang B. 
Silver-mediated radical C(sp3)-H biphosphinylation and
nitration of β-alkynyl ketones for accessing functional isochromenes . Org. Lett. 
2017 , 19 , 754 –757 . 10.1021/acs.orglett.6b03546 .28157317

